Skip to main content

Large-Scale Expansion of Umbilical Cord Mesenchymal Stem Cells with Microcarrier Tablets in Bioreactor

  • Protocol
  • First Online:
Bioreactors in Stem Cell Biology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2436))

Abstract

Mesenchymal stem cells show great potential in tissue engineering and cell-based therapies. This protocol demonstrates the use of 3D TableTrix® microcarrier tablets for large-scale manufacturing of human umbilical cord mesenchymal stem cells (hUCMSCs) in a 5-L stirred tank bioreactor. 3D TableTrix® microcarrier tablets readily disperse into tens of thousands of porous microcarriers to simplify cell seeding, and 3D FloTrix® vivaSPIN bioreactor could automate, monitor, and control the entire culture process. 3D TableTrix® microcarriers could also be fully dissolved upon adding dissolution reagent to gently harvest the expanded cells at a high recovery rate. With this protocol, more than 109 cells could be produced in a 5-L bioreactor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yin S, Ji C, Wu P, Jin C, Qian H (2019) Human umbilical cord mesenchymal stem cells and exosomes: bioactive ways of tissue injury repair. Am J Transl Res 11(3):1230

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Li T, Xia M, Gao Y, Chen Y, Xu Y (2015) Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy. Expert Opin Biol Ther 15(9):1293–1306. https://doi.org/10.1517/14712598.2015.1051528

    Article  CAS  PubMed  Google Scholar 

  3. Yaghoubi Y, Movassaghpour A, Zamani M, Talebi M, Mehdizadeh A, Yousefi M (2019) Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment. Life Sci 233:116733. https://doi.org/10.1016/j.lfs.2019.116733

    Article  CAS  PubMed  Google Scholar 

  4. Lee WY, Wang B (2017) Cartilage repair by mesenchymal stem cells: clinical trial update and perspectives. J Orthop Translat 9:76–88. https://doi.org/10.1016/j.jot.2017.03.005

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lam AT, Lee AP, Jayaraman P, Tan KY, Raghothaman D, Lim HL, Cheng H, Zhou L, Tan AH, Reuveny S, Oh S (2021) Multiomics analyses of cytokines, genes, miRNA, and regulatory networks in human mesenchymal stem cells expanded in stirred microcarrier-spinner cultures. Stem Cell Res 53:102272. https://doi.org/10.1016/j.scr.2021.102272

    Article  CAS  PubMed  Google Scholar 

  6. Mabvuure N, Hindocha S, Khan WS (2012) The role of bioreactors in cartilage tissue engineering. Curr Stem Cell Res Ther 7(4):287–292

    Article  CAS  Google Scholar 

  7. Yan X, Zhang K, Yang Y, Deng D, Lyu C, Xu H, Liu W, Du Y (2020) Dispersible and dissolvable porous microcarrier tablets enable efficient large-scale human mesenchymal stem cell expansion. Tissue Eng Part C Methods 26(5):263–275. https://doi.org/10.1089/ten.TEC.2020.0039

    Article  CAS  PubMed  Google Scholar 

  8. Zamani F, Zare Shahneh F, Aghebati-Maleki L, Baradaran B (2013) Induction of CD14 expression and differentiation to monocytes or mature macrophages in Promyelocytic cell lines: new approach. Adv Pharm Bull 3(2):329–332. https://doi.org/10.5681/apb.2013.053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wang K, Wei G, Liu D (2012) CD19: a biomarker for B cell development, lymphoma diagnosis and therapy. Exp Hematol Oncol 1(1):1–7

    Article  Google Scholar 

  10. Ding DC, Chang YH, Shyu WC, Lin SZ (2015) Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant 24(3):339–347. https://doi.org/10.3727/096368915X686841

    Article  PubMed  Google Scholar 

  11. Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, Gorodetsky R (2006) Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37(10):967–976. https://doi.org/10.1038/sj.bmt.1705358

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work is financially supported by Beijing Municipal Science & Technology Commission (Z181100001818005) and R&D program (RC21-01) of Beijing CytoNiche Biotechnology Co. Ltd.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaojun Yan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Xu, H., Cong, Z., Zhang, Y., Liu, W., Yan, X., Du, Y. (2021). Large-Scale Expansion of Umbilical Cord Mesenchymal Stem Cells with Microcarrier Tablets in Bioreactor. In: Turksen, K. (eds) Bioreactors in Stem Cell Biology. Methods in Molecular Biology, vol 2436. Humana, New York, NY. https://doi.org/10.1007/7651_2021_425

Download citation

  • DOI: https://doi.org/10.1007/7651_2021_425

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-2017-5

  • Online ISBN: 978-1-0716-2018-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics